To examine specific cardiometabolic biomarkers and growth trajectories in adolescents with vs without PCOS, stratified by BMI category.
Key Findings:
14% of participants met criteria for PCOS, indicating a notable prevalence.
Adolescents with PCOS and BMI <85th percentile had earlier peak height velocity and significantly higher insulin resistance.
No significant differences in adiposity measures by PCOS status within either BMI category.
Interpretation:
PCOS in adolescents, even those with normal BMI, is associated with increased insulin resistance and adverse adipokine profiles, indicating significant metabolic dysfunction that warrants clinical attention.
Limitations:
Study focused on a specific cohort, limiting generalizability to broader populations.
Cross-sectional nature may not establish causality, making it difficult to infer temporal relationships.
Conclusion:
Lean adolescents with PCOS exhibit significant metabolic dysfunction, highlighting the need for awareness and early identification of PCOS risk regardless of body weight.
Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.
